TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 53 filers reported holding TFF PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,409 | -26.1% | 846,884 | -0.8% | 0.00% | – |
| Q2 2023 | $401,221 | -31.9% | 853,663 | -0.7% | 0.00% | – |
| Q1 2023 | $588,980 | -34.7% | 859,449 | 0.0% | 0.00% | – |
| Q4 2022 | $902,422 | -74.4% | 859,449 | -1.0% | 0.00% | – |
| Q3 2022 | $3,526,000 | -28.1% | 868,431 | 0.0% | 0.00% | – |
| Q2 2022 | $4,907,000 | -10.1% | 868,431 | +0.4% | 0.00% | – |
| Q1 2022 | $5,458,000 | -24.2% | 864,983 | +6.5% | 0.00% | – |
| Q4 2021 | $7,203,000 | +17.4% | 812,170 | +2.2% | 0.00% | – |
| Q3 2021 | $6,138,000 | -17.2% | 795,038 | +3.0% | 0.00% | – |
| Q2 2021 | $7,417,000 | -21.6% | 771,854 | +10.8% | 0.00% | – |
| Q1 2021 | $9,457,000 | +5.4% | 696,907 | +11.2% | 0.00% | – |
| Q4 2020 | $8,975,000 | +47.5% | 626,770 | +90.2% | 0.00% | – |
| Q3 2020 | $6,086,000 | +1562.8% | 329,531 | +418.3% | 0.00% | – |
| Q2 2020 | $366,000 | +50.0% | 63,584 | 0.0% | 0.00% | – |
| Q1 2020 | $244,000 | -12.2% | 63,584 | +22.2% | 0.00% | – |
| Q4 2019 | $278,000 | – | 52,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,019,848 | $7,873,000 | 15.20% |
| Mesirow Financial Investment Management, Inc. | 40,005 | $309,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 80,000 | $618,000 | 0.59% |
| DRW Securities, LLC | 1,000,000 | $7,720,000 | 0.34% |
| GAGNON SECURITIES LLC | 282,229 | $2,179,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 128,037 | $988,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 145,295 | $1,122,000 | 0.11% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $170,000 | 0.10% |
| CARLSON CAPITAL L P | 227,701 | $1,758,000 | 0.09% |
| MYDA Advisors LLC | 40,000 | $309,000 | 0.09% |